Pyronaridine
- Generic Name
- Pyronaridine
- Drug Type
- Small Molecule
- Chemical Formula
- C29H32ClN5O2
- CAS Number
- 74847-35-1
- Unique Ingredient Identifier
- TD3P7Q3SG6
- Background
Pyronaridine has been investigated for the treatment of Malaria.
- Indication
本品用于治疗脑型、凶险型及耐氯喹虫珠所致的恶性疟，也用于治疗间日疟。
- Associated Conditions
- Acute Falciparum Malaria, Acute Malaria caused by plasmodium vivax
Malaria Drug Pyronaridine Shows Promise as Novel Cancer Treatment
• UTEP researchers secure patent for repurposing pyronaridine, a 30-year-old antimalarial drug, as a potential cancer treatment targeting multiple cancer types.
• The drug demonstrates a triple mechanism of action: slowing cancer cell growth, inducing programmed cell death, and showing minimal impact on healthy cells.
• Initial pilot studies by Armaceutica on late-stage cancer patients showed increased longevity, though further clinical trials are needed to validate safety and efficacy.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath